Phase III Venetoclax Dexamethasone vs Pomalidomide Dexamethasone in t1114Positive RRMM
Full Title:
A Phase 3 Multicenter Randomized Open Label Study of Venetoclax and Dexamethasone Compared with Pomalidomide and Dexamethasone in Subjects with t1114Positive Relapsed or Refractory Multiple Myeloma
Status:
OPEN TO ACCRUAL
Protocol Number:
2007883925
Principal Investigator:
Phase:
III
Prevention or Control:
Age Group:
Scope:
Disease Site(s):
Multiple Myeloma
National Institutes of Health - ClinicalTrials.gov NCT Number: NCT03539744